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Background: Induced sputum cell counts are a non-invasive, reliable method for evaluating the presence, type,
and degree of inflammation in the airways of the lungs. Current reference values for induced sputum cell counts in
healthy adults do not account for the effects of circadian rhythm, including diurnal variation. The objective of this
study was to describe the diurnal variation in induced sputum cell counts, compared between early morning and
late afternoon, in healthy adult individuals.
Methods: 100 healthy adult subjects with no history of lung disease and normal bronchial reactivity proceeded
with induced sputum testing at 7 am and 4 pm on different days. The order of testing was randomized. The
cytotechnologist preparing and performing the cell counts was blinded to the sample collection time and subject
characteristics.
Results: 65 subjects were included in the final analyses. There was no significant change in the total and
differential sputum cell counts between the 7 am and 4 pm collections. There was good inter-observer agreement
with respect to differential sputum cell count interpretation.
Conclusions: This is the largest study to assess the variation in induced sputum cell counts in healthy adult
subjects at different times of the day. We found no significant change in total and differential sputum cell counts
between the 7 am and 4 pm collection time points. This is in contrast to studies in asthmatics that demonstrated a
circadian variation in sputum cell counts and other markers of inflammation, suggesting that fluctuations in airway
inflammatory cells during the day are a disease-specific effect.
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Induced sputum cell counts are a non-invasive, reliable
method for evaluating the presence, type, and degree of
inflammation in the airways of the lungs [1-3]. Sputum
cell counts can be used clinically to assist with manage-
ment of underlying airway inflammation, including titra-
tion of inhaled corticosteroid therapy in patients with
asthma [4]. Tailoring asthma management based on spu-
tum eosinophil counts has been shown to be effective in
reducing asthma exacerbations [4-7] and is now consid-
ered standard of care for adults with moderate to severe
asthma in the most recent iteration of the Canadian
asthma guidelines [8].* Correspondence: wdavidso@ucalgary.ca
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reproduction in any medium, provided the orAs in many other biological systems, circadian rhythms
are known to have an impact on the respiratory system. In
healthy subjects, endogenous circadian rhythms contrib-
ute to diurnal changes in pulmonary function [9]. In asth-
matic patients, there is a circadian influence on airway
resistance and lung volumes [10,11]. Moreover, asthmatics
have been shown to have decreased lung function at night
and early morning [12]. Analysis of bronchoalveolar lavage
fluid in patients with asthma has revealed a circadian al-
teration in lymphocytes and a variety of cytokines [13,14].
One small study examining the circadian changes in in-
duced sputum in 11 asthmatic patients demonstrated an
increase in early morning total sputum leukocytes and
eosinophils [15]. Whether these changes are a normal re-
sponse or specific to asthma remains to be determined.
Current reference values for induced sputum cell counts
in healthy adults do not account for the effects ofal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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stand the effect of normal circadian variation, including
diurnal variation, on induced sputum cell counts in
healthy non-asthmatic individuals, especially when testing
for clinical or research purposes can be performed at vari-
ous times throughout the day. Understanding whether
these alterations are disease-specific or simply reflect cir-
cadian influences on normal airway biology will improve
our interpretation of induced sputum cell counts in the in-
vestigation and management of inflammatory airways dis-
orders, and will further standardize clinical and research
methodologies. Therefore, the aim of this study was to
evaluate the diurnal changes in induced sputum cell
counts in healthy adult subjects. We hypothesized that,
similar to patients with asthma, total sputum leukocytes




The study was approved by the Institutional Research
Ethics Board and written informed consent was obtained
from all subjects. Adult study participants were eligible
for inclusion into the study, provided they had no his-
tory of any chronic respiratory conditions and had nor-
mal spirometry (forced expiratory volume in one second
[FEV1] >80% predicted and forced expiratory volume in
one second to forced vital capacity ratio [FEV1/FVC]
>0.75), with no significant bronchodilator response
(FEV1 and FVC <200 mL increase and <12% increase
following short-acting bronchodilator administration).
Potential study participants were excluded from the
study if they had any of the following: a positive
methacholine challenge test (defined here as a provoca-
tive concentration of methacholine required to give a
20% reduction in baseline FEV1 (PC20) <16 mg/mL); a
smoking history ≥5 pack years or had smoked within the
past 12 months; a history of atopy; a history of rhinitis
symptoms; a diagnosed upper respiratory tract infection
4 weeks prior to study participation; or a history of any
inflammatory condition considered by the investigators
to be clinically relevant, including any underlying auto-
immune disorder, infectious disease, immunodeficiency,
malignancy or clinically relevant cardiovascular, neuro-
logical, endocrine or hematological disorder. Women
who were pregnant, or who were planning on become
pregnant during the study period, and women who were
breastfeeding were also excluded. Finally, only those
study participants who provided written informed con-
sent were included in the study.
Study design
The primary objective was to describe the diurnal vari-
ation in induced sputum cell counts, compared betweenearly morning and late afternoon, in healthy adult
individuals.
Study participants attended our laboratory on three sep-
arate occasions. During the first visit, the subject’s medical
history was reviewed to determine if they met inclusion/
exclusion criteria. Pre- and post-bronchodilator spirom-
etry was completed and a methacholine challenge test
was performed. Suitable candidates were randomized to
undergo initial induced sputum collection at either 7 am
or 4 pm. At the second visit subjects performed the first
induced sputum test. Subjects were asked to return 2–5
days later to complete the second induced sputum collec-
tion. To assess the subjects’ sleep patterns prior to each
sputum collection, including any disruption to their usual
duration of sleep, the subjects answered standardized
questions about their usual weekly sleep habits and their
sleep schedule during the study period.
The randomization sequence was computer-generated
and stored in opaque, sealed envelopes that were held by
an individual not involved in the study.
Procedures
Pulmonary function testing
Spirometry, pre- and post-bronchodilator administra-
tion, and methacholine challenge testing were performed
according to American Thoracic Society (ATS) guide-
lines [18,19].
Sputum induction and processing
Induced sputum collection was performed using ac-
cepted techniques as per standardized guidelines [20].
Sputum was induced with escalating concentrations of
hypertonic saline (4%, 4%, 5%). Subjects inhaled the
hypertonic saline for 7 minutes for each concentration.
If the baseline FEV1 fell by >20%, or if the subject
experienced respiratory distress, the procedure was
discontinued and treatment with inhaled bronchodilator
was given. Spirometry was repeated to ensure the FEV1
improved to within 10% of baseline. After induction,
10 mL of 10% buffered formalin (Starplex Scientific Inc,
Etobicoke, Ont) was added to the sample container, as
described previously [21]. Sputum samples were batched
in groups of 4 or 6 and sent for processing by a cyto-
technologist blinded to the collection times. The expec-
torated preserved sputum was poured into a petri dish
and examined. Colour was noted and dense areas were
chosen for processing. The sample was then suspended
in phosphate-buffered saline (PBS) and rocked for
10 minutes before being centrifuged (500 rpm × g for
10 min). After centrifugation, the supernatant was re-
moved and the sample was briefly vortexed. These steps
were repeated three times. A solution of 2.5% trypsin
(3 times volume to sputum weight) was added to the
sample and the solution was then incubated at 37°C
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manually using a Bright-line neubuer hemacytometer
(Hausser Scientific, Horsham, PA). The cells were di-
luted in PBS to 1 × 106/ml and cytospin slides were pre-
pared, before being stained with Congo red, after which
differential sputum cell counts were performed on 400
non-squamous cells. Samples were considered adequate
for analysis if there was <20% squamous cell contamin-
ation. Measurements were compared with standardized
values [16]. Cell counts were performed by an experi-
enced cytotechnologist blinded to subject characteristics
and sputum sample collection times. To assess inter-
observer agreement in the differential sputum cell count,
both slides from 20 subjects were recounted by a second
experienced cytotechnologist, who was also blinded to
subject characteristics and sputum sample collection
times. Given that the samples were preserved in forma-
lin, analysis of sputum fluid-phase mediators, including
cytokines and chemokines, could not be performed. Cell
viability could not be determined.
Sample size and statistical analysis
Belda et al. measured induced sputum cell counts in
healthy adults, without reference to time of sample col-
lection, and found a mean total cell count of 4.13 × 106
cells/gram (standard deviation (SD) 4.8 × 106 cells/gram)
[16]. Panzer et al. found an increase in total sputum leu-
kocytes and eosinophils at 7 am compared with 4 pm in
patients with mild asthma [15]. Based on the cell counts
from the Belda study and the increase in early morning
sputum cell counts in the Panzer study, we calculated
that 63 subjects would be required to detect a 50% in-
crease in total cell counts in the 7 am collection com-
pared with the 4 pm collection, using a one-sided test, a
power of 0.80, and an alpha level of 0.05.
Values from the different sputum collections were com-
pared using the paired t-test for normally distributed data
and the Wilcoxon signed rank test for non-parametric
data. To assess inter-observer agreement, Bland-Altman
plots were performed and the intra-class correlation coef-
ficient was calculated. For the primary outcome of change
in total sputum cell count, a p-value <0.05 was considered
statistically significant. To account for multiple analyses, a
p-value <0.01 was considered statistically significant for
the differential sputum cell counts.
Results
Study subjects
Subject enrolment started in January 2010 and ended in
March 2012. Subject flow is summarized in Figure 1. Of
the 100 subjects who volunteered to participate, 11 were
excluded due to a positive methacholine challenge test,
16 were withdrawn due to difficulties attending all re-
quired study visits, and 8 were excluded as at least oneof their sputum samples was unsatisfactory for interpret-
ation. Sixty-five subjects were included in the final ana-
lyses. Subject characteristics at baseline are listed in
Table 1. The majority of the subjects were Caucasian
(n = 50) and female (n = 40). The study population had
normal spirometry. None of the subjects were taking
regular medications at the time of enrolment.
Changes in airway inflammatory cells
Table 2 summarizes the induced sputum cell count re-
sults. There was no significant change in the total and
differential sputum cell counts between the 7 am and
4 pm collections. Although there appeared to be a
change in absolute macrophage cell count, the p-value
did not reach our a priori cut-off for differential cell
counts (p < 0.01) and therefore was considered not to be
statistically significant. The time between sputum collec-
tions was approximately 5 days [mean 125.4 hours
(SD 82.2 hours)].
Inter-observer agreement
Sputum samples from 20 subjects were randomly se-
lected for differential sputum cell count interpretation
by a second cytotechnician blinded to subject charac-
teristics and sputum sample collection times. Bland-
Altman analysis revealed good inter-observer agreement
(Figure 2 and Table 3). For the neutrophil and macro-
phage analyses, the ratio of the measurements was plot-
ted, avoiding the need for log transformation of the data.
The eosinophil analysis plotted the difference of the
measurements. The intra-class correlation coefficient
(ICC) revealed very good agreement for the sputum neu-
trophils and macrophages while there was moderate
agreement for the sputum eosinophil counts (Table 3).
Sleep questionnaire
Subjects slept for a shorter duration [median 7 hours
(IQR 6.1,7.5)] prior to the 7 am collection than the 4 pm
collection [median 7.4 hours (IQR 7,8)] (p = 0.0027).
During an average week, subjects slept for a shorter dur-
ation [7.5 hours (IQR 7,8)] compared with the weekend
[median 8 hours (IQR 8,9)] (p < 0.0001). Prior to the
7 am sputum collection, subjects slept for a slightly
shorter duration compared with their usual weekday
(p = 0.002), while there was no difference in the amount
of weekday sleep prior to the 4 pm sputum collection
(p = 0.66). Six subjects reported napping during an aver-
age week [mean 0.42 hours (SD 0.31 hours)] and 8 sub-
jects during an average weekend [mean 0.91 hours (SD
0.36 hours)]. Ten subjects reported that they perform
shift work with 7 subjects reporting working a nightshift
prior to one of the sputum collections. However, in this
group of subjects there was no difference in the total
evening sleep duration before each sputum collection












Sputum samples unsuitable 
for analysis (n=8)
Completed study and included in 
analyses
(n=65)
Figure 1 Subject flow.








BMI, kg/m2 29.7 (4.8)
Smoking, Pack-years 0.3 (1)
FEV1, L 3.52 (3.13,4.17)
FEV1 (% pred) 106 (97,114)
FVC, L 4.42 (3.89,5.52)
FVC (% pred) 109 (98,120)
FEV1/FVC, % 0.8 (0.77,0.85)
Definition of abbreviations: BMI = body mass index, FEV1 = forced expiratory
volume in one second, FRC = functional residual capacity, FVC = forced vital
capacity. Parametric data are shown as mean (SD). Non-parametric variables
are reported as median (IQR).
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4 pm collection.Discussion
This is the largest study to assess the potential impact of
diurnal variation on induced sputum cell counts in
healthy subjects at different times of the day. We found
no significant change in total and differential sputum
cell counts between the 7 am and 4 pm collection times.Table 2 Change in sputum cell counts
7 am 4 pm p-value
Total cell count, x106/g 2 (0.95,3.55) 1.39 (0.75,2.97) 0.34
Neutrophils, % 51.5 (35,68) 51 (35,68) 0.84
Neutrophils, x106/g 0.81 (0.33,1.37) 0.81 (0.28,1.32) 0.96
Eosinophils, % 0.7(0,2) 0.5 (0,2) 0.36
Eosinophils, x106/g 0.0069 (0,0.049) 0.005 (0,0.027) 0.08
Macrophages, % 39.3 (25,57) 37.3 (20,61) 0.44
Macrophages, x106/g 0.67 (0.30,1.39) 0.44 (0.29,0.73) 0.033
Lymphocytes, % 1 (0,2.5) 0.75 (0,3) 0.46
Lymphocytes, x106/g 0.005 (0,0.51) 0.0076 (0,0.0385) 0.076
Variables reported as median (IQR); p-value derived from the Wilcoxon
signed-rank test.
Figure 2 Bland-Altman plots of the inter-observer agreement for differential sputum cell counts. Sputum neutrophil, eosinophil, and
macrophage cell counts are represented in plots (a), (b), and (c), respectively. The dashed lines represent the inter-observer bias (± 1.96 SD). For
the neutrophil and macrophage analyses, the ratio of the measurements was plotted, avoiding the need for log transformation of the data. The
eosinophil analysis plotted the difference of the measurements. Definition of abbreviations: A = first cytotechnologist cell count; B = second
cytotechnologist cell count.
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changes in sputum cell counts in healthy controls [22].
Popov and colleagues performed sputum induction at
8 am and 8 pm in 13 asthmatics admitted to hospital for
asthma exacerbations and 10 hospital volunteers [22]. In
the “control group”, the authors reported a higher total
cell count in the morning (median 0.75 × 103 cells/mL,
IQR 0.31-2.25 × 103 cells/mL) compared with the even-
ing collection (median 0.33 × 103 cells/mL, IQR 0.1-
0.97 × 103 cells/mL, p < 0.001). Sputum eosinophil levels
were lower in the evening, whereas macrophages were
increased. However, this study had a number of potential
limitations, making interpretation of the results difficult.
The sample size was small at 10 healthy controls with
no justification of the sample size. Inclusion/exclusion
criteria for the control subjects were not provided. The
collection of the sputum at the different time points didTable 3 Bland-Altman analysis of inter-observer bias in sputu
Neutrophils (x106/g)
Inter-observer bias (± 1.96 STD)* 0.94 + 0.74
ICC (95% CI) 0.998 (0.996 to 0.999)
* Ratio of the measurements was plotted for neutrophils and macrophages; differen
abbreviations: CI = confidence interval; ICC = Intra-class correlation coefficient; STD =not appear to be randomized and the timing between
sputum induction was not described. It was not clear if
the cytotechnologist preparing and counting the sputum
samples was blinded to the study subjects and collection
times. There was no testing for inter-observer agree-
ment. Furthermore, there was no adjustment for mul-
tiple comparisons. Our current study now extends our
knowledge in this area by clearly controlling for all of
these potential limitations present in this earlier study.
Previous studies have shown diurnal variation in pul-
monary function in healthy subjects [23,24]. Spengler
et al. found that endogenous circadian rhythms, rather
than diurnal alterations in behavior or environment, are
factors in these diurnal changes [9]. There have been
many studies examining the effect of circadian variation
in asthma-related inflammation, including induced spu-
tum [15], bronchoalveolar lavage fluid inflammatory cellsm cell counts
Eosinophils(x106/g) Macrophages (x106/g)
−0.02 ± 0.17 1.3 ± 2.5
0.593 (0.231 to 0.785) 0.988 (0.978 to 0.994)
ce of the measurements was plotted for eosinophils. Definition of
standard deviation of the difference.
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[26,27], and transbronchial biopsies [28]. Our finding of
an absence of any significant change in sputum cell
counts in healthy subjects at different time points during
the day suggests that the circadian/diurnal variation in
inflammation previously reported in asthmatic patients
is intrinsic to the disease.
In an effort to reduce systematic bias, we randomized
the start time of the first induced sputum collection. Al-
though the respiratory therapist performing the induced
sputum test could not be blinded, the cytotechnologist
preparing the samples and performing the cell counts
was blinded to collection time. Use of the formalin pres-
ervation technique allowed us to keep the cytotechnician
blinded. That is, without the formalin preservation, the
sample would have been processed within 2 hours of
collection, alerting the cytotechnician to the collection
time. The good inter-observer agreement confirmed that
the differential sputum cell count results were reliable.
We scheduled the second induced sputum collection
more than 48 hours after the first collection as repeated
induced sputum procedures within 48 hours have been
shown to alter the cellular composition of sputum
[29-31]. To minimize the chance of external factors al-
tering the sputum composition between collections, we
requested that the second collection occur within 5 days
of the first test. From the sleep data collected, we did
not find a significant difference in the amount of sleep
prior to each of the collections. Furthermore, no subjects
napped during the day prior to the 4 pm collection. Sub-
jects did sleep approximately 30 minutes less than a
usual weekday prior to the 7 am test but this was not
surprising, as they were required to be in the laboratory
just prior to 7 am.
Given the need for a delayed sputum analysis, we gen-
tly mixed all sputum samples with 10% buffered forma-
lin immediately after collection. The use of formalin as a
preservation method for induced sputum processing has
been validated previously [32]. Specifically, Kelly et al.
compared two methods of sputum processing: (1) a
(para)formaldehyde-dithiothreitol (DTT) mixture dis-
persed with trypsin (preservation method), and (2) im-
mediate processing with DTT (routine method). Good
agreement between the techniques was found, along
with good within-method repeatability for the preserva-
tion method, thereby confirming that this method is
valid and reliable. Further, no increase in degenerate
changes and no interference of cell counts by debris
were found [33]. This technique has subsequently been
successfully used to process sputum samples in a remote
collection site [34]. Additionally, this method of preser-
vation has been shown to have no adverse effect on sam-
ple quality and sputum cell counts [21]. Viability of the
preserved cells could not be determined. The standardmethod of measuring cell viability using the trypan blue
exclusion technique [35] was not possible as the forma-
lin resulted in cell death. Formalin preserved cells have
good morphology and cell counts, total and differential,
may be performed in the same way as for the DTT
method [32].
Current reference values for absolute and percentage
induced sputum cell counts in healthy adults were de-
rived from two major studies [16,17]. In our study, the
sputum absolute and percentage cell counts most closely
resembled those of Belda and colleagues [16]. We found
a slightly lower absolute and percentage neutrophil
count. Eosinophil cell count, absolute and percentage,
were only slightly higher in our study, as was the vari-
ability in the range of these values. Compared with the
findings of Spanevello et al. [17], our results showed a
slightly higher percentage of sputum neutrophils and a
lower percentage of macrophages. The differences may
be a result of the formalin fixation method used in our
study. While DTT may reduce cell viability [36,37], for-
malin rapidly inactivates cellular enzymes and may
stabilize the cell membrane when added to induced
sputum samples [32]. It is possible that use of the pres-
ervation technique may have improved cell viability and
cellular recovery compared with previous studies
reporting normal cell count values.
There are several study limitations. First, the time
points chosen were limited by availability of the labora-
tory to perform induced sputum collection during rou-
tine working hours. We cannot comment whether the
cellular composition of sputum changes at other points
during the very early morning or late evening. However,
on a practical basis, it is likely that sputum induction
and collection is most commonly performed during day-
time hours. Second, given that we required delay sample
analysis, we had to preserve the samples. As a result, we
were not able to assess whether sputum fluid-phase me-
diators, such as sputum cytokines, normally vary during
the day. Third, although subjects were excluded if they
had a history of atopy, we did not perform allergy skin
prick testing on all study subjects. Thus, it is possible
that some patients may have had underlying atopy with
no clinical history.
Conclusion
This is the largest study to assess the variation in in-
duced sputum cell counts in healthy adult subjects at
different times of the day. We found no significant
change in total and differential sputum cell counts be-
tween the 7 am and 4 pm collection time points. This is
in contrast to studies in asthmatics that have demon-
strated a circadian variation in sputum cell counts and
other markers of inflammation, suggesting that fluctua-
tions in airway inflammatory cells during the day are a
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inflammation exhibit circadian variation in healthy subjects
remains to be determined. Our results provide evidence
that the timing of daytime induced sputum collection, by
itself, does not affect sputum cell count results.
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